Drug
Febuxostat
Febuxostat: highest development phase Phase 3, developed by Menarini. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Febuxostat NCT01724528 | Phase 3 | Tumor Lysis Syndrome |
| Febuxostat NCT03605212 | Phase 1/2 | Tumor Lysis Syndrome |
Latest
No recent events.
Follow Febuxostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.